Literature DB >> 1204238

Activation of the classical and alternate pathways of complement by Corynebacterium parvum.

W H McBride, D M Weir, A B Kay, D Pearce, J R Caldwell.   

Abstract

The immunological adjuvant Corynebacterium parvum has been to activate the alternate pathway of complement in human and guinea-pig serum. Human serum in addition contains anti-C. parvum antibodies leading to activation of the classical complement pathway. The possible role of a C. parvum derived polysaccharide in this activation is considered in relation to the biological effects of the micro-organism.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1204238      PMCID： PMC1538020     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


  10 in total

1.  [STIMULATION OF THE PHAGOCYTIC ACTIVITY OF THE RETICULOENDOTHELIAL SYSTEM BY CORYNEBACTERIUM PARVUM].

Authors:  B N HALPERN; A R PREVOT; G BIOZZI; C STIFFEL; D MOUTON; J C MORARD; Y BOUTHILLIER; C DECREUSEFOND
Journal:  J Reticuloendothel Soc       Date:  1964-01

2.  Tumour growth, phagocytic activity and antibody response in Corynebacterium parvum-treated mice.

Authors:  M F Woodruff; W H McBride; N Dunbar
Journal:  Clin Exp Immunol       Date:  1974-07       Impact factor: 4.330

3.  Role of complement in induction of the allergic response.

Authors:  M B Pepys
Journal:  Nat New Biol       Date:  1972-05-31

4.  Immune hemolysis: a simplified method for the preparation of EAC'4 with guinea pig or with human complement.

Authors:  T Borsos; H J Rapp
Journal:  J Immunol       Date:  1967-08       Impact factor: 5.422

5.  The C3-activator system: an alternate pathway of complement activation.

Authors:  O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

6.  Increased phagocytic cell activity and anaemia in Corynebacterium parvum treated mice.

Authors:  W H McBride; J T Jones; D M Weir
Journal:  Br J Exp Pathol       Date:  1974-02

7.  Adjuvant-induced antired blood cell activity in CBA mice.

Authors:  A McCracken; W H McBride; D M Weir
Journal:  Clin Exp Immunol       Date:  1971-06       Impact factor: 4.330

8.  Inhibition of tumour growth by administration of killed corynebacterium parvum.

Authors:  B N Halpern; G Biozzi; C Stiffel; D Mouton
Journal:  Nature       Date:  1966-11-19       Impact factor: 49.962

9.  Inhibitory effect of injection of Corynebacterium parvum on the growth of tumour transplants in isogenic hosts.

Authors:  M F Woodruff; J L Boak
Journal:  Br J Cancer       Date:  1966-06       Impact factor: 7.640

10.  Complement-dependent B-cell activation by cobra venom factor and other mitogens?

Authors:  P Dukor; G Schumann; R H Gisler; M Dierich; W König; U Hadding; D Bitter-Suermann
Journal:  J Exp Med       Date:  1974-02-01       Impact factor: 14.307
  10 in total
  14 in total

1.  The characteristics of binding of Corynebacterium parvum to glass-adherent mouse peritoneal exudate cells.

Authors:  H M Ogmundsdóttir; D M Weir
Journal:  Clin Exp Immunol       Date:  1976-11       Impact factor: 4.330

2.  Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation.

Authors:  H U Schorlemmer; D Bitter-Suermann; A C Allison
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

3.  Effects of intravenous injection of two different strains of Corynebacterium parvum in the mouse.

Authors:  T E Sadler; P D Jones; J E Castro; I A Lampert
Journal:  Br J Exp Pathol       Date:  1979-12

4.  Activation of the alternative pathway of complement by Malassezia ovalis (Pityrosporum ovale).

Authors:  P W Belew; E W Rosenberg; B R Jennings
Journal:  Mycopathologia       Date:  1980-03-31       Impact factor: 2.574

5.  An ultrastructural study of peritoneal mononuclear phagocytes from Corynebacterium parvum-injected mice.

Authors:  R G Pugh-Humphreys; A W Thomson
Journal:  Br J Exp Pathol       Date:  1979-06

6.  Effect of muralytic enzyme degradation of streptococcal cell wall on complement activation in vivo and in vitro.

Authors:  M J Janusz; R A Eisenberg; J H Schwab
Journal:  Inflammation       Date:  1987-03       Impact factor: 4.092

7.  Complement activation in acne vulgaris: in vitro studies with Propionibacterium acnes and Propionibacterium granulosum.

Authors:  G F Webster; J J Leyden; M E Norman; U R Nilsson
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

8.  Effects of a heat-labile factor(s) in normal serum on the interferon-inducing activity of Newcastle disease virus (NDV). Brief report.

Authors:  F Taguchi; Y Nishimura
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

9.  Biphasic protection against bacterial infection in mice induced by vaccination of Propionibacterium acnes.

Authors:  F Kobayashi; T Nagoya; T Koshi; Y Saino
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

10.  Chemotactic efficiency of various chemoattractants for polymorphonuclear leukocytes in inflammatory acne vulgaris.

Authors:  J Knop; T Bossecker; P M Kövary
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.